Literature DB >> 12633114

Novel class of tertiary phosphine ligands based on a phospha-adamantane framework and use in the Suzuki cross-coupling reactions of aryl halides under mild conditions.

George Adjabeng1, Tim Brenstrum, Jeffrey Wilson, Christopher Frampton, Al Robertson, John Hillhouse, James McNulty, Alfredo Capretta.   

Abstract

[reaction: see text] A new class of sterically hindered phosphines based on a phospha-adamantane framework is described. Arylation or alkylation of the 1,3,5,7-tetramethyl-2,4,8-trioxa-6-phospha-adamantane system allows for the preparation of tertiary phosphines suitable for use in palladium-catalyzed cross-coupling reactions. For example, use of a catalytic system incorporating Pd(2)(dba)(3) and 1,3,5,7-tetramethyl-2,4,8-trioxa-6-phenyl-6-phospha-adamantane is shown to promote the Suzuki cross-coupling of aryl iodides, bromides, and activated chlorides with a variety of aryl boronic acids at room temperature in a few hours with high yields.

Entities:  

Year:  2003        PMID: 12633114     DOI: 10.1021/ol0341647

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Room-temperature borylation and one-pot two-step borylation/Suzuki-Miyaura cross-coupling reaction of aryl chlorides.

Authors:  Hong Ji; Li-Yang Wu; Jiang-Hong Cai; Guo-Rong Li; Na-Na Gan; Zhao-Hua Wang
Journal:  RSC Adv       Date:  2018-04-11       Impact factor: 4.036

2.  Evaluation of P-bridged biaryl phosphine ligands in palladium-catalysed Suzuki-Miyaura cross-coupling reactions.

Authors:  Jairus L Lamola; Paseka T Moshapo; Cedric W Holzapfel; Munaka Christopher Maumela
Journal:  RSC Adv       Date:  2021-08-05       Impact factor: 4.036

3.  Challenging nickel-catalysed amine arylations enabled by tailored ancillary ligand design.

Authors:  Christopher M Lavoie; Preston M MacQueen; Nicolas L Rotta-Loria; Ryan S Sawatzky; Andrey Borzenko; Alicia J Chisholm; Breanna K V Hargreaves; Robert McDonald; Michael J Ferguson; Mark Stradiotto
Journal:  Nat Commun       Date:  2016-03-23       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.